The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

21 Sep 2015 07:00

RNS Number : 5922Z
CATCo Reinsurance Opps Fund Ltd
21 September 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in CATCo Reinsurance Opportunities Fund Ltd. or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.

 

CATCo Reinsurance Opportunities Fund Ltd.

 

21 September 2015

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

 

 

Potential Equity Issue

 

The Company today announces that the Board and the Company's investment manager, CATCo Investment Management Ltd. (the "Manager") believe that the Company is appropriately positioned to continue to deliver attractive returns through its focused strategy. As a result of consultations with certain existing Shareholders, it is considering fundraising options for investment into the January 2016 portfolio.

Following recent meetings held by the Manager with a number of existing and potentially new clients of CATCo-Re Ltd. (the "Reinsurer") (through which the Company indirectly invests in fully collateralised reinsurance contracts), interest levels in the Reinsurer's retrocessional protections have been seen to be much greater than that experienced in prior years.

A further announcement will be made in due course.

 

For further information, please contact:

CATCo Investment Management Ltd. Judith Wynne, General CounselMobile: +44 7986 205364Telephone: +1 441 493 9005 Email: judith.wynne@catcoim.com 

Mark Way, Investor Relations DirectorMobile: +44 7786 116991 Telephone: +1 441 293 0050Email: mark.way@catcoim.com

Numis Securities Limited David Benda / Hugh Jonathan Telephone: +44 (0) 20 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEDBLFLEKFZBBX
Date   Source Headline
24th May 20064:36 pmRNSRule 8.3- Cambrdige Antibody
24th May 20064:24 pmRNSEPT Disclosure
24th May 20063:55 pmRNSRule 8.3- Cambridge Antibody
24th May 20063:35 pmRNSHolding(s) in Company
24th May 20063:20 pmRNSHolding(s) in Company
24th May 20061:40 pmRNSHolding(s) in Company
24th May 200612:16 pmRNSEPT Disclosure
24th May 200611:46 amRNSEPT Disclosure
24th May 200610:11 amRNSRule 8.3- Cambridge Antibody
24th May 20067:02 amRNSRule 8.1- Cambridge Antibody
23rd May 20066:07 pmRNSMarket Maker Holding
23rd May 20065:01 pmRNSEPT Disclosure
23rd May 20064:29 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:35 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:17 pmRNSRule 8.3- Cambridge Antibody
23rd May 200611:46 amRNSEPT Disclosure
23rd May 200611:46 amRNSRule 8.3- Cambridge Antibody
23rd May 200611:42 amRNSEPT Disclosure
23rd May 20067:01 amRNSAstraZeneca Offer for CAT
22nd May 20062:40 pmRNSRule 8.3- Cambridge Antibody
22nd May 20062:37 pmRNSRule 8.3- Cambridge Antibody
22nd May 200612:31 pmRNSEPT Disclosure
22nd May 200611:52 amRNSEPT Disclosure
22nd May 200611:41 amRNSEPT Disclosure
22nd May 20067:01 amRNSInterim Results
19th May 20065:41 pmRNSRule 8.3- Cambridge Antibody
19th May 20064:46 pmRNSEPT Disclosure
19th May 200612:49 pmRNSEPT Disclosure
19th May 200612:16 pmRNSEPT Disclosure
18th May 20065:08 pmRNSEPT Disclosure - Amendment
18th May 20065:05 pmRNSHolding(s) in Company
18th May 20064:28 pmRNSHolding(s) in Company
18th May 20064:27 pmRNSHolding(s) in Company
18th May 20064:25 pmRNSHolding(s) in Company
18th May 20064:00 pmRNSEPT Disclosure
18th May 20063:03 pmRNSRule 8.3- Cambridge Antibody
18th May 200611:44 amRNSEPT Disclosure
18th May 200611:21 amRNSNotice of Results
18th May 200611:08 amRNSEPT Disclosure
18th May 200610:54 amRNSHolding(s) in Company
18th May 20067:00 amRNSMarket Maker Holding
17th May 20063:46 pmRNSRule 8.3- Cambridge Antibody
17th May 20062:55 pmRNSEPT Disclosure - Amendment
17th May 200612:31 pmRNSEPT Disclosure
17th May 200612:28 pmRNSEPT Disclosure
17th May 200611:20 amRNSEPT Disclosure
17th May 200611:00 amRNSMerger Update
17th May 200610:31 amRNSRule 8.3- Cambridge Antibody
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.